MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Clinical trials for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY trials appear
Sign up with your email to follow new studies for MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a fatty acid drug stop dangerous blood sugar drops in MCADD?
Disease control Recruiting nowThis study tests a drug called triheptanoin in 24 people aged 4 and older with MCADD, a rare genetic condition that can cause dangerously low blood sugar. The drug is already approved for similar disorders and may help keep glucose levels stable. Researchers will monitor safety a…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
Fatty acid study sheds light on rare metabolic disease
Knowledge-focused Recruiting nowThis study looks at how medium-chain and long-chain fatty acids affect the body in people with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) and in healthy volunteers. Researchers will measure ketone levels and resting metabolism after fat intake. The goal is to better u…
Matched conditions: MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
Phase: NA • Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC